COMPANY

Everest Detection

Profile checked Oct 10, 2026

Keywords: Lung Cancers

Timeline

Feb 17, 2025 Trial start —: Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers source ↗

Jun 30, 2029 (ESTIMATED) · · Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers · NCT06816121

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06816121	Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Heavy Smokers	Not listed	Recruiting	Feb 17, 2025	Jun 30, 2029 (estimated)